Heather Harris
Adult Health · Baton Rouge, LANPI 1619155686
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 96.4% of the total across 185 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 21 manufacturers, the largest accounting for just 18.2% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $1,149, 2.2 times the $530 reported in 2021.
Across 185 payments — averaging $19.54 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$658
- Johnson & Johnson$553
- Madrigal Pharmaceuticals$432
- Gilead$379
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$300
- Intercept Pharmaceuticals, Inc.$208
- plus $1K from 15 others
What the payments were for
- Food & beverage$3,48396%
- Education$1324%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 42 | $658 |
| Johnson & Johnson | 28 | $553 |
| Madrigal Pharmaceuticals | 16 | $432 |
| Gilead | 19 | $379 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 18 | $300 |
| Intercept Pharmaceuticals, Inc. | 10 | $208 |
| Pfizer | 8 | $149 |
| Ardelyx, Inc. | 7 | $148 |
| Sanofi | 6 | $131 |
| Takeda Pharmaceuticals U.S.A., Inc. | 6 | $122 |
| Ipsen Biopharmaceuticals, Inc | 6 | $122 |
| QOL Medical, LLC | 5 | $120 |
| Braintree Laboratories, Inc. | 3 | $77 |
| Ironwood Pharmaceuticals, Inc | 3 | $61 |
| Phathom Pharmaceuticals, Inc. | 2 | $34 |
| Echosens North America, Inc. | 1 | $25 |
| Aimmune Therapeutics, Inc. | 1 | $22 |
| Nestle Healthcare Nutrition Inc. | 1 | $21 |
| Evoke Pharma, Inc. | 1 | $20 |
| Redhill Biopharma Inc. | 1 | $18 |
| Intra-sana Laboratories | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- REZDIFFRA$123
How this compares
$3,615 in reported general payments places this provider in the 70th percentile of 203 adult health providers in Louisiana.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OcalivaObeticholic Acid | 12 | $88,215 |
| LinzessLinaclotide | 120 | $82,725 |
| XifaxanRifaximin | 14 | $49,355 |
| CreonLipase/Protease/Amylase | 15 | $44,219 |
| VemlidyTenofovir Alafenamide | 13 | $21,034 |
| MotegrityPrucalopride Succinate | 17 | $9,483 |
| Sucralfate | 50 | $7,521 |
| Sod Sulf-Potass Sulf-Mag SulfSodium, Potassium,mag Sulfates | 108 | $6,796 |
| Ursodiol | 32 | $4,553 |
| Colestipol Hcl | 28 | $3,585 |
| Mesalamine | 11 | $2,568 |
| ClenpiqSod Picosulf/Mag Ox/Citric Ac | 14 | $2,378 |
| Lubiprostone | 26 | $1,589 |
| Pantoprazole Sodium | 180 | $1,038 |
| Omeprazole | 76 | $971 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieLinzess, Creon | $658 | $126,944135 claims |
| Intercept Pharmaceuticals, Inc.Ocaliva | $208 | $88,21512 claims |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLCXifaxan | $300 | $49,35514 claims |
| GileadVemlidy | $379 | $21,03413 claims |
| Takeda Pharmaceuticals U.S.A., Inc.Motegrity | $122 | $9,48317 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 203 adult health providers in Louisiana.
Other adult health in Baton Rouge
- Joan SmithBaton Rouge$121K
- Deborah SmithBaton Rouge$18K
- Tanisha SmithBaton Rouge$17K
- Eva Marina StaffordBaton Rouge$15K
- Dustin DenicolaBaton Rouge$14K
- Wendy GillBaton Rouge$13K
- Jennifer LeblancBaton Rouge$12K
- Carrie PerryBaton Rouge$6K
- Auldyn HirscheyBaton Rouge$6K
- Colette BlanchardBaton Rouge$6K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.